Doctor profile · Federal record
Dr. Uzoamaka Ukoha, MD
Dermatology Physician (CMS: Dermatology) · Dallas, TX
- NPI 1073041125
- Accepts Medicare
- MIPS 81.3 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8200 Walnut Hill Ln
Dallas, TX 752314426
(214) 345-6789 - Mailing address
-
8169 Precinct Line RD Bldg 2
North Richland Hills, TX 761828607
Credentials & registration
- NPI registered
- June 2017 — 9 yrs on file
- Profile last updated
- June 18, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #S4700
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073041125. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
287
Distinct HCPCS
8
Medicare allowed
$31,016
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 98 | 49 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 60 | 43 | $91 | |
11102 |
Biopsy of related skin growth, first growth | 27 | 23 | $91 | |
17110 |
Destruction of skin growth, 1-14 growths | 25 | 18 | $115 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 24 | 24 | $113 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 20 | 20 | $168 | |
17000 |
Destruction of precancer skin growth, 1 growth | 18 | 14 | $50 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 15 | 11 | $57 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 1.3× the peer median.Open Payments
Industry payments received
All-time total
$744
Transactions
38
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 8 | $201.12 | |
| Abbvie INC. | 13 | $169.11 | |
| Ucb, INC. | 2 | $67.89 | |
| Regeneron Healthcare Solutions, INC. | 2 | $51.43 | |
| Lilly USA, LLC | 2 | $49.91 | |
| Leo Pharma INC. | 2 | $38.13 | |
| Arcutis Biotherapeutics, INC. | 2 | $35.36 | |
| Pfizer INC. | 2 | $31.32 | |
| Novartis Pharmaceuticals Corporation | 1 | $24.88 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $21.73 | |
| Incyte Corporation | 1 | $20.20 | |
| Journey Medical Corporation | 1 | $19.71 | |
| Strata Skin Sciences, INC. | 1 | $13.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
702
Patients
366
Total drug cost
$349,191
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 217 | 129 | $13,063 |
| Ketoconazole | Generic | 101 | 51 | $2,419 |
| Hydrocortisone | Generic | 80 | 54 | $648 |
| Triamcinolone Acetonide | Generic | 64 | 44 | $995 |
| Clindamycin Phosphate | Generic | 37 | 22 | $2,150 |
| Tacrolimus | Generic | 37 | 17 | $7,456 |
| Tretinoin | Generic | 36 | 20 | $3,665 |
| Dupixent Pen (Dupilumab) | Brand | 31 | 0 | $114,274 |
| Mupirocin | Generic | 22 | 17 | $205 |
| Humira(Cf) Pen (Adalimumab) | Brand | 14 | 0 | $202,488 |
Hospital affiliations
Frequently asked questions
What is Dr. Uzoamaka Ukoha's medical specialty?
Dr. Uzoamaka Ukoha practices Dermatology Physician in Dallas, TX.
Where does Dr. Uzoamaka Ukoha practice?
Dr. Uzoamaka Ukoha practices at 8200 Walnut Hill Ln, Dallas, TX 752314426. Office phone: 2143456789.
What is Dr. Uzoamaka Ukoha's NPI?
Dr. Uzoamaka Ukoha's National Provider Identifier (NPI) is 1073041125, issued by NPPES.
Does Dr. Uzoamaka Ukoha accept Medicare assignment?
Yes. Dr. Uzoamaka Ukoha accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Uzoamaka Ukoha commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.